| Firm |
Analyst |
| Bank ofAmerica/Merrill Lynch
|
Rachel McMinn, PhD |
| Brean Murray, Carret & Co
|
Brian Skorney, CFA |
| Canaccord|Genuity
|
George Farmer |
| Citi
|
Yaron Weber, MD |
| Cowen & Co.
|
Phil Nadeau, PhD |
| CSFB
|
Adam Cutler |
| Goldman Sachs
|
Terence Flynn |
| JMP Securities
|
Liisa Bayko |
| J.P. Morgan Securities
|
Geoffrey Meacham, PhD |
| Leerink Swann
|
Howard Liang, PhD |
| Morgan Stanley
|
David Friedman, MD |
| Nobel Financial
|
Nathan Cali |
| Piper Jaffray
|
Edward Tenthoff |
| ThinkEquity
|
Marko Kozul, MD |
| William Blair
|
Katherine Xu, PhD |
| Robert W. Baird & Co.
|
Thomas J. Russo, CFA |
| UBS
|
Matt Roden, PhD |
| Wells Fargo Securities
|
Brian Abrahams, MD |
Pharmasset, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Pharmasset, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Pharmasset, Inc. or its management. Pharmasset, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.